Seegnal eHealth
Prescription Operating System
Company Overview
Snapshot
Founded in September 2015, Seegnal eHealth operates with 11–50 employees. The company became public on the TSXV in August 2025, a significant milestone in its journey to commercialize its clinical decision-support platform.
Business overview
Seegnal eHealth develops a smart and intuitive clinical decision-support platform designed to empower clinicians in managing and resolving patient-specific drug-related problems. The platform integrates with electronic medical records and other relevant systems, incorporating a wide range of data into a patented interface. Utilizing proprietary real-time algorithms and exclusive data from leading global sources, Seegnal aims to improve patient care and safety, reduce healthcare expenditures, and diminish alert fatigue and clinician burnout. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare, Clinical Workflow, and Medical Decision Support.
Strategic signal
In June 2026, Seegnal successfully initiated its first U.S. pilot program and was accepted into an innovative accelerator program from AARP, marking a strategic push into the American healthcare market. This signals a critical phase of market penetration and validation for its medication safety platform, indicating potential for significant growth and broader adoption in a key global market.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent market expansion for Seegnal eHealth?
- In June 2026, Seegnal eHealth successfully initiated its first U.S. pilot program, marking its initial penetration into the American healthcare market. This was further bolstered by its acceptance into an innovative accelerator program from AARP.
- When did Seegnal eHealth become a publicly traded company?
- Seegnal eHealth became public on the TSXV in August 2025, following the completion of a qualifying transaction.
- What recent product development did Seegnal eHealth announce?
- In October 2025, Seegnal Inc. announced the release of its new "MetricsGuard" Clinical Decision Support Module, enhancing its platform's capabilities.
- Has Seegnal eHealth expanded its presence in the Israeli market recently?
- In June 2026, Seegnal announced plans to deploy its medication safety platform across Nazareth Hospital EMMS, expanding its Israeli hospital footprint.
- What recent leadership change occurred at Seegnal Inc.?
- In November 2025, Seegnal Inc. announced the appointment of Elad Bibi-Aviv as its new Chief Executive Officer.